Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study

Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study

Chen Wang,1 Tieying Sun,1 Yijiang Huang,2 Michael Humphries,3 Lingyan Bai,3 Lilly Li,3 Qian Wang,3 Pearl Kho,4 Roz Firth,4 Peter D'Andrea51Beijing Hospital, Dongcheng District, Beijing, People's Republic of China; 2Hainan Provincial People's Hospital, Xiuying District, Haikou...

Full description

Bibliographic Details
Main Authors: Wang C, Sun T, Huang Y, Humphries M, Bai L, Li L, Wang Q, Kho P, Firth R, D’Andrea P
Format: Article
Language:English
Published: Dove Medical Press 2015-01-01
Series:International Journal of COPD
Online Access:http://www.dovepress.com/efficacy-and-safety-of-once-daily-glycopyrronium-in-predominantly-chin-peer-reviewed-article-COPD

Internet

http://www.dovepress.com/efficacy-and-safety-of-once-daily-glycopyrronium-in-predominantly-chin-peer-reviewed-article-COPD

Similar Items